彪马
PBYI
9.83
-0.69
-6.56%
彪马
US · PBYI
#3745 按市值排名
9.83
-0.69
-6.56%
实时 - 追踪5344个代码 - 心跳于169秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例下降了1.2个百分点。
机构持股
- 机构持股比例
- 75.48% -1.22pp
- 机构数量
- 194 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund56.76%
Individual/Insider15.18%
VC/PE Fund8.00%
Hedge Fund7.38%
Government Pension Fund1.32%
Public Company1.03%
Private Company0.47%
Family Office/Trust0.32%
Insurance Company0.11%
Other9.42%
主要股东 截至 2026-07-06
Alan Auerbach
13.74% · 7.09M 股
Acorn Bioventures
8.00% · 4.13M 股
BlackRock
7.37% · 3.80M 股
American Century Investment Management
4.49% · 2.32M 股
Vanguard Capital Management, LLC
4.08% · 2.10M 股
Acadian Asset Management LLC
3.98% · 2.05M 股
Renaissance Technologies Corp.
3.56% · 1.84M 股
Vanguard Portfolio Management, LLC
3.54% · 1.83M 股
LSV Asset Management
3.13% · 1.62M 股
Dimensional Fund Advisors
2.94% · 1.52M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 13次买入 · 37次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Alan Auerbach | Founder, Chairman, President, CEO & Secretary | 13.74% |
| Maximo Nougues | Chief Financial Officer | 0.35% |
| Douglas Hunt | Senior Vice President of Regulatory Affairs, Pharmacovigilance, Medical Affairs & Law | 0.29% |
| Jeffrey Ludwig | Chief Commercial Officer | 0.18% |
| Brian Stuglik | Independent Director | 0.17% |
| Allison Dorval | Independent Director | 0.12% |
| Michael Miller | Independent Director | 0.10% |
| Jay Moyes | Lead Independent Director | 0.06% |
| Alessandra Cesano | Director | 0.06% |
| Troy Wilson | Independent Director | 0.05% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-13 | Troy Wilson | Independent Director | Open Market Disposition | -5,000 | $9.10 |
| 2026-09-13 | Alessandra Cesano | Director | Open Market Disposition | -12,150 | $9.12 |
| 2026-09-13 | Alessandra Cesano | Director | Derivative Exercise and Sale | -50,000 | $2.93–9.12 |
| 2026-07-05 | Alan Auerbach | Founder, Chairman, President, CEO & Secretary | Automatic Disposition | -44,058 | $8.26 |
| 2026-07-05 | Douglas Hunt | Senior Vice President of Regulatory Affairs, Pharmacovigilance, Medical Affairs & Law | Automatic Disposition | -8,460 | $8.26 |
| 2026-07-05 | Maximo Nougues | Chief Financial Officer | Automatic Disposition | -9,386 | $8.26 |
| 2026-06-11 | Jay Moyes | Lead Independent Director | Automatic Disposition | -22,000 | $7.22 |
| 2026-06-11 | Troy Wilson | Independent Director | Automatic Disposition | -10,800 | $7.20 |
| 2026-06-11 | Adrian Senderowicz | Independent Director | Automatic Disposition | -27,000 | $7.20 |
| 2026-06-11 | Allison Dorval | Independent Director | Automatic Disposition | -11,610 | $7.20 |
| 2026-06-11 | Brian Stuglik | Independent Director | Automatic Disposition | -8,100 | $7.20 |
| 2026-06-10 | Jay Moyes | Lead Independent Director | Other Acquisition | +27,000 | -- |
| 2026-06-10 | Michael Miller | Independent Director | Other Acquisition | +27,000 | -- |
| 2026-06-10 | Troy Wilson | Independent Director | Other Acquisition | +27,000 | -- |
| 2026-06-10 | Alessandra Cesano | Director | Other Acquisition | +27,000 | -- |
| 2026-06-10 | Adrian Senderowicz | Independent Director | Other Acquisition | +27,000 | -- |
| 2026-06-10 | Allison Dorval | Independent Director | Other Acquisition | +27,000 | -- |
| 2026-06-10 | Brian Stuglik | Independent Director | Other Acquisition | +27,000 | -- |
| 2026-02-17 | Alan Auerbach | Founder, Chairman, President, CEO & Secretary | Other Acquisition | +159,778 | -- |
| 2026-02-17 | Alan Auerbach | Founder, Chairman, President, CEO & Secretary | Other Derivative Acquisition | +227,474 | $6.68 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
彪马 讨论区 0 条评论